{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:40:29Z","timestamp":1793400029862,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.atherosclerosis.2015.10.108","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T14:09:05Z","timestamp":1446646145000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"special_numbering":"C","title":["L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE\u2212\/\u2212 transgenic mice expressing CETP"],"prefix":"10.1016","volume":"244","author":[{"given":"Heidi L.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Drazul-Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Sulpizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toran","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1894-2939","authenticated-orcid":false,"given":"Aouatef","family":"Bellamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib1","unstructured":"World Health Organization. Cardiovascular diseases (CVDs) Fact Sheet No 317. In: 2011."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib2","unstructured":"Copyright World Health Organization. http:\/\/www.who.int\/cardiovascular_diseases\/en\/. In: 2015."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","article-title":"Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective","volume":"25","author":"Alexander","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib4","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra035098","article-title":"Cardiovascular disease","volume":"349","author":"Nabel","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nut.2014.08.011","article-title":"Nutritional factors in the prevention and management of coronary artery disease and heart failure","volume":"31","author":"Das","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2013.10.013","article-title":"Gut microbiota metabolism of L-carnitine and cardiovascular risk","volume":"231","author":"Ussher","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib9","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/nm.2895","article-title":"A\u00a0complex microworld in the gut: gut microbiota and cardiovascular disease connectivity","volume":"18","author":"Howitt","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2013.05.019","article-title":"Gut microbiota: an environmental risk factor for cardiovascular disease","volume":"229","author":"Stock","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.metabol.2015.01.007","article-title":"New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis","volume":"64","author":"Drosos","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A\u00a0human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.phrs.2009.11.001","article-title":"Interactions of gut microbiota with functional food components and nutraceuticals","volume":"61","author":"Laparra","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.copbio.2010.03.020","article-title":"Programming infant gut microbiota: influence of dietary and environmental factors","volume":"21","author":"Marques","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00592-011-0333-6","article-title":"Gut microbiota and diabetes: from pathogenesis to therapeutic perspective","volume":"48","author":"Burcelin","year":"2011","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2014.11.011","article-title":"The microbiome in asthma","volume":"135","author":"Huang","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/07315724.2013.799982","article-title":"Risk factors for cardiovascular disease: a cautionary tale of diet-microbiome interactions","volume":"32","author":"Miller","year":"2013","journal-title":"J.\u00a0Am. Coll. Nutr."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.gendis.2014.08.001","article-title":"Exploring gut microbes in human health and disease: pushing the envelope","volume":"1","author":"Sun","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib21","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1172\/JCI72331","article-title":"The contributory role of gut microbiota in cardiovascular disease","volume":"124","author":"Tang","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2008.08.008","article-title":"Carnitine in metabolic disease: potential for pharmacological intervention","volume":"120","author":"Arduini","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/phrs.2001.0852","article-title":"L-carnitine prevents the progression of atherosclerotic lesions in hypercholesterolaemic rabbits","volume":"44","author":"Sayed-Ahmed","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mayocp.2013.02.007","article-title":"L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"88","author":"DiNicolantonio","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib26","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","article-title":"Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide","volume":"35","author":"Wang","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1242\/jeb.188.1.175","article-title":"Role of urea and methylamines in buoyancy of elasmobranchs","volume":"188","author":"Withers","year":"1994","journal-title":"J.\u00a0Exp. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","article-title":"gamma-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO","volume":"20","author":"Koeth","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/364073a0","article-title":"Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein","volume":"364","author":"Marotti","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/01.ATV.19.4.1105","article-title":"Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression","volume":"19","author":"Plump","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2007.08.001","article-title":"Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice","volume":"197","author":"de","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib35","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/ATVBAHA.108.171363","article-title":"Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice","volume":"28","author":"van der Hoorn","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"Llera-Moya","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-2697(78)90586-9","article-title":"A\u00a0modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples","volume":"87","author":"Markwell","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/CIRCULATIONAHA.107.704254","article-title":"Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport","volume":"116","author":"Tanigawa","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib39","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0022-2275(20)39713-3","article-title":"Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice","volume":"36","author":"Tangirala","year":"1995","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A\u00a0rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib41","first-page":"50","article-title":"The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges","author":"Greaves","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.ATV.20.3.773","article-title":"The pathogenesis of foam cell formation: modified LDL stimulates uptake of co-incubated LDL via macropinocytosis","volume":"20","author":"Jones","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib43","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/dmd.110.037895","article-title":"The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5","volume":"39","author":"Xie","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib46","first-page":"390","article-title":"Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes","volume":"25","author":"Guo","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000139525","article-title":"Anti-inflammatory action of methimazole","volume":"55","author":"Lagorce","year":"1997","journal-title":"Pharmacology"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib48","first-page":"83","article-title":"Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease","volume":"34","author":"Sewerynek","year":"2000","journal-title":"Endocr. Regul."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0305-0491(87)90056-3","article-title":"The influence of diet and carnitine supplementation on plasma carnitine, cholesterol and triglyceride in WHHL (Watanabe-heritable hyperlipidemic), Netherland dwarf and New Zealand rabbits (Oryctolagus cuniculus)","volume":"87","author":"Bell","year":"1987","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00002512-200320100-00004","article-title":"Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue","volume":"20","author":"Pistone","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib51","first-page":"45","article-title":"Zur Kenntnis der Extraktionsstoffe der Muskeln. 2. Mitteilungen\u00fcber das Carnitin (extracted substances in muscle, report on carnitine)","author":"Gulewitsch","year":"1905","journal-title":"Physiol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib52","first-page":"85","article-title":"[The biological function of L-carnitine and its content in the particular food examples]","volume":"70","author":"Rospond","year":"2013","journal-title":"Przegl Lek."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib53","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nut.2004.04.003","article-title":"Supplementation of L-carnitine in athletes: does it make sense?","volume":"20","author":"Karlic","year":"2004","journal-title":"Nutrition"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-8703(79)90440-X","article-title":"Role of carnitine in fatty acid metabolism of normal and ischemic myocardium","volume":"97","author":"Opie","year":"1979","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib55","series-title":"TMAO Treatment Does Not Affect Foam Cell Formation (Cholesterol Mass Loading) and Cholesterol Efflux in J774 Mouse Macrophage","author":"Bellamine","year":"2014"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1165\/rcmb.2013-0320OC","article-title":"Chemical chaperones mitigate experimental asthma by attenuating endoplasmic reticulum stress","volume":"50","author":"Makhija","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib57","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1110\/ps.0372903","article-title":"Measuring the stability of partly folded proteins using TMAO","volume":"12","author":"Mello","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib58","first-page":"2829","article-title":"Trimethylamine N-oxide alleviates the severe aggregation and ER stress caused by G98R alphaA-crystallin","volume":"15","author":"Gong","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jbt.2570100308","article-title":"Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice","volume":"10","author":"Falls","year":"1995","journal-title":"J.\u00a0Biochem. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/abbi.1997.9965","article-title":"Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids","volume":"342","author":"Falls","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib61","doi-asserted-by":"crossref","first-page":"BR389","DOI":"10.12659\/MSM.883478","article-title":"The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis","volume":"18","author":"Jawien","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2006.02.026","article-title":"Doxycycline affects diet- and bacteria-associated atherosclerosis in an ApoE heterozygote murine model: cytokine profiling implications","volume":"190","author":"Madan","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0021-9150(94)05460-Z","article-title":"Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits","volume":"114","author":"Spagnoli","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.gene.2013.03.010","article-title":"Flavin containing monooxygenase 3 genetic polymorphisms Glu158Lys and Glu308Gly and their relation to ischemic stroke","volume":"521","author":"Turkanoglu","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2015.10.108_bib65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/FJC.0000000000000197","article-title":"Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients","volume":"65","author":"Fukami","year":"2015","journal-title":"J.\u00a0Cardiovasc Pharmacol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015301921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015301921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T04:43:23Z","timestamp":1653453803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015301921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":65,"alternative-id":["S0021915015301921"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.108","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE\u2212\/\u2212 transgenic mice expressing CETP","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}